首页> 外国专利> B-BROMO B-PHENYL A- (5-BROMO-THIENYL-2) A- (4-HYDROXYPHENYL) ETHYLENE DERIVATIVES AS MEDICAMENTS FOR THE TREATMENT OF PROSTATIC CONDITIONS AND IN PARTICULAR PROSTATE TUMORS AND ASSOCIATIONS CONTAINING THESE DERIVATIVES

B-BROMO B-PHENYL A- (5-BROMO-THIENYL-2) A- (4-HYDROXYPHENYL) ETHYLENE DERIVATIVES AS MEDICAMENTS FOR THE TREATMENT OF PROSTATIC CONDITIONS AND IN PARTICULAR PROSTATE TUMORS AND ASSOCIATIONS CONTAINING THESE DERIVATIVES

机译:B-溴代B-苯酚A-(5-溴代-噻吩基-2)A-(4-羟基苯乙炔)亚乙基衍生物作为治疗前列腺疾病的药物,尤其是前列腺肿瘤和包含这些衍生物的药物

摘要

P THESE ARE THE NEUTRAL SALT AND THE BASIC MAGNESIUM SALT OF ETHYLENE B-BROMO B-PHENYL A- (5-BROMO-THIENYL-2) A- (PHENYL-4-OXYACETIC) ACID RESPONDING TO FORMULASI AND II BELOW AND IN THE FORM OF A POWDERY SOLID WITHOUT TOXICITY. THEY ARE ADMINISTRABLE TO MAN WITH A DAILY EFFECTIVE DOSE OF 300 TO 600MG OF ACTIVE SUBSTANCE, ORALLY IN THE FORM OF CAPSULES OR ORAL BULBS CONTAINING 100 OR 200MG OF THIS SUBSTANCE. THESE DERIVATIVES MAY BE ASSOCIATED WITH ONE OR LESS OF THE KNOWN MEDICINAL PRODUCTS USED TO TREAT BENIGN OR CANCER TUMORS OF PROSTATE. /P
机译:

这些是下面和下面对应于分子式和II的乙烯B-溴B-苯甲基A-(5-溴-噻吩基-2)A-(苯基-4-氧代乙酸)的中性盐和碱性镁盐粉末状固体,无毒。对于每天有效剂量为300到600毫克的有效物质,通常以含100或200毫克这种物质的胶囊或口服小灯泡的形式,他们是容易接受的。这些衍生物可能与一种或多种用于治疗前列腺癌或前列腺癌的已知医药产品有关。

著录项

  • 公开/公告号FR2530629A1

    专利类型

  • 公开/公告日1984-01-27

    原文格式PDF

  • 申请/专利权人 ARVIS GABRIELLE;ARVIS GABRIELLE;

    申请/专利号FR19820009919

  • 发明设计人

    申请日1982-06-08

  • 分类号C07D333/28;A61K31/38;A61K33/06;

  • 国家 FR

  • 入库时间 2022-08-22 08:45:16

相似文献

  • 专利
  • 外文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号